Literature DB >> 15312175

Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.

Tao Pan1, Ruliang Li, Shin-Cheng Kang, Boon-Seng Wong, Thomas Wisniewski, Man-Sun Sy.   

Abstract

We used anti-prion (PrP) monoclonal antibodies (Mabs) in different combinations to scan changes in the availability of antibody binding epitopes--using an epitope scanning assay--in brain homogenates from normal mice, and from mice infected with either ME7 or 139 A strains of infectious scrapie prion (PrPSc). In ME7-infected brains, the epitope detected by the Mab pair 8B4/8H4 is reduced, while the epitope detected by the Mab pair 8F9/11G5 is increased. Mab 8F9/11G5 detect a conformational epitope on PrPSc because the rise in Mab 8F9/11G5 binding is sensitive to a denaturing agent but resistant to proteinase K (PK). While the increase in Mab 8F9/11G5 binding correlates with the presence of PK-resistant PrP and clinical signs of infection, the reduction in Mab 8B4/8H4 binding is detected earlier. Fractionation of the ME7-infected brain homogenate in sucrose gradient revealed that the PrPSc species detected by the epitope scanning assay are heterogeneous in size, with a molecular mass of approximately > or = 2000-kDa. We also investigated whether these findings were applicable to two other strains of PrPSc, namely 87 V and 22 L. We found that the decrease in Mab 8B4/8H4 binding detected in ME7-infected brains was also detected in 87 V-infected brains but not in 22 L-infected brains. In contrast, the increase in Mab 8F9/11G5 binding detected in ME7- and 139 A-infected brains was also detected in 22 L-infected brains but not in 87 V-infected brains. Therefore, each prion strain has its unique conformation, and we can monitor the conversion of normal cellular prion (PrPC) to PrPSc based on the changes in the antibody binding patterns. The epitope can be decreased or increased, linear or conformational, detected late or early during infection, in a strain specific manner. Copyright 2004 International Society for Neurochemistry

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312175     DOI: 10.1111/j.1471-4159.2004.02582.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates.

Authors:  Tao Pan; Binggong Chang; Poki Wong; Chaoyang Li; Ruliang Li; Shin-Chung Kang; John D Robinson; Andrew R Thompsett; Po Tein; Shaoman Yin; Geoff Barnard; Ian McConnell; David R Brown; Thomas Wisniewski; Man-Sun Sy
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.

Authors:  Tao Pan; Poki Wong; Binggong Chang; Chaoyang Li; Ruliang Li; Shin-Chung Kang; Thomas Wisniewski; Man-Sun Sy
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.

Authors:  Joanna Pankiewicz; Frances Prelli; Man-Sun Sy; Richard J Kascsak; Regina B Kascsak; Daryl S Spinner; Richard I Carp; Harry C Meeker; Marcin Sadowski; Thomas Wisniewski
Journal:  Eur J Neurosci       Date:  2006-05       Impact factor: 3.386

4.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

5.  Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease.

Authors:  Rebecca M Nisbet; Christopher F Harrison; Victoria A Lawson; Colin L Masters; Roberto Cappai; Andrew F Hill
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

6.  Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.

Authors:  Brian O'Nuallain; Amy Allen; Stephen J Kennel; Deborah T Weiss; Alan Solomon; Jonathan S Wall
Journal:  Biochemistry       Date:  2007-02-06       Impact factor: 3.162

7.  PrP antibody binding-induced epitope modulation evokes immunocooperativity.

Authors:  Binggong Chang; Michael W Miller; Marie S Bulgin; Sharon Sorenson-Melson; Aru Balachandran; Allen Chiu; Richard Rubenstein
Journal:  J Neuroimmunol       Date:  2008-10-31       Impact factor: 3.478

8.  Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity.

Authors:  Sandra McCutcheon; Jan P M Langeveld; Boon Chin Tan; Andrew C Gill; Christopher de Wolf; Stuart Martin; Lorenzo Gonzalez; James Alibhai; A Richard Alejo Blanco; Lauren Campbell; Nora Hunter; E Fiona Houston
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

9.  The Role of Prion Protein Expression in Predicting Gastric Cancer Prognosis.

Authors:  Zhaoqing Tang; Ji Ma; Wei Zhang; Changguo Gong; Jing He; Ying Wang; Guohua Yu; Chonggang Yuan; Xuefei Wang; Yihong Sun; Jiyan Ma; Fenglin Liu; Yulan Zhao
Journal:  J Cancer       Date:  2016-05-20       Impact factor: 4.207

10.  A New Cell Model for Investigating Prion Strain Selection and Adaptation.

Authors:  Alexandra Philiastides; Juan Manuel Ribes; Daniel Chun-Mun Yip; Christian Schmidt; Iryna Benilova; Peter-Christian Klöhn
Journal:  Viruses       Date:  2019-09-22       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.